Clinical Trial Update: Permeability Factor in Focal Segmental Glomerulosclerosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 studies evaluated a permeability factor in focal segmental glomerulosclerosis. The trial results were posted in 2016 and the study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Focal Segmental Glomerulosclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-02-10